Floatz logo

ZINC SULFATE

Patient Outcome Assessment

Laboratoire De Recherche Sur Le Diabete, Université de TlemcenSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Patient Outcome Assessment cohort.

Same molecule, other indications

ZINC SULFATE is also rated in:

Splenectomy; StatusDormant
BB
Indicative ·
69 / 100
View asset →
acquired immunodeficiencyDormant
BB
Indicative ·
69 / 100
View asset →
thalassemiaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →